-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Reiterates Buy on IDEAYA Biosciences, Lowers Price Target to $57

Benzinga·11/04/2026 16:20:59
Listen to the news
Truist Securities analyst Gregory Renza reiterates IDEAYA Biosciences (NASDAQ:IDYA) with a Buy and lowers the price target from $59 to $57.